Q3 Revenue Jumps 66% Sequentially to $4.8M as Gross Profit Turns Positive
XXII is trading near its 52-week low of $0.721 (1.6% below the low) on elevated volume (36× avg).
Summary
Revenue rose 66% sequentially to $4.8 million from $2.9 million in Q2, and gross profit flipped to $0.4 million from a $(0.3) million loss. Versus the year-ago quarter, revenue was up 18.6% to $4.759 million while the operating loss narrowed to $2.6 million from $3.2 million and the adjusted EBITDA loss improved to $2.2 million from $2.9 million. The growth is coming from higher-margin cigarette sales ($3.9 million, up from $2.3 million) as the company shifts away from low-priced CMO export customers; VLN cigarette revenue was still just $0.03 million. Management also flagged a 166% sequential increase in point-of-sale pack sales at its retail launch partner, a GoPuff distribution deal, approvals in 13 more states and shipments into roughly 150 new stores in metro New York and northern New Jersey. Post-quarter they raised $5.8 million net through the ATM, used $1.2 million to redeem Series B preferred at par, and now have no warrants outstanding — a cleaner cap table after the 1-for-58 reverse split effective November 5. Cash stood at $3.9 million on September 30, so the ATM remains the funding lifeline; the 8:00 a.m. ET call is the next checkpoint on margin durability and VLN sell-through. The quarter's loss per share was $247.80.
At the time of this announcement, XXII was trading at $0.71 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $424.2K. The 52-week trading range was $0.72 to $20,314.46. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.